DR. PHILOMENA F. MCANDREW, M.D.

Plain English
This study looked at how triple negative breast cancer responds to treatment with the drug pembrolizumab and radiation therapy. Researchers found that patients can be grouped based on their tumor's immune characteristics before treatment: about 1/3 of patients show a strong immune system response even before starting therapy, while others only start to respond after receiving both the drug and radiation. This is important because it helps identify which patients might need additional treatments to boost their response to immunotherapy. Who this helps: This helps patients with triple negative breast cancer and their doctors make better treatment decisions.

Plain English
This study looked at the safety and effectiveness of combining radiation therapy with the drug pembrolizumab before starting chemotherapy in patients with certain types of breast cancer, including triple-negative breast cancer. Out of 66 patients, 59.2% of those with triple-negative breast cancer and 33.3% of those with hormone receptor-positive breast cancer showed a complete response to treatment, with an overall 3-year event-free survival rate of 80%. The findings indicate that this treatment combination is safe and may help improve outcomes for patients with these breast cancer types. Who this helps: This benefits breast cancer patients, particularly those with triple-negative and hormone receptor-positive forms.

Plain English
Researchers studied the effects of combining a cancer-fighting drug called pembrolizumab with two different chemotherapy drugs (paclitaxel and capecitabine) in women with metastatic triple-negative breast cancer, which is a hard-to-treat type of breast cancer. They found that the combination of pembrolizumab with paclitaxel had a response rate of 29%, while the combination with capecitabine was even better, with a 43% response rate. Both treatment combinations were considered safe, showing no severe side effects in most patients. Who this helps: This study benefits women with metastatic triple-negative breast cancer by providing new treatment options.

Plain English
This research focused on assessing how accessible Massive Open Online Courses (MOOCs) are for all users, especially those with disabilities. The study involved both expert evaluations and feedback directly from users, leading to the development of a new auditing process to improve these courses. Making MOOCs more accessible is important because it ensures that everyone, regardless of their abilities, can benefit from online education. Who this helps: This helps students with disabilities and educators who create online courses.

Plain English
This study looked at whether Black and Minority Ethnic (BME) nurses and male nurses are being unfairly referred to the Nursing and Midwifery Council (NMC) for misconduct in the NHS. It found that BME nurses are referred at a rate of 1.4 times higher than white nurses, and male nurses are referred about 1.3 times more than female nurses. This matters because it highlights potential discrimination in the disciplinary process, which can impact the careers of these nurses and the overall quality of care in the NHS. Who this helps: This helps nurses and healthcare organizations working towards fair treatment and practices.

Plain English
This study focused on understanding how the enzyme IRE1α responds to stress caused by misfolded proteins in cells. Researchers found that the activity of IRE1α, which helps manage this stress, increases significantly when it undergoes a process called autophosphorylation. Specifically, they discovered that enhancing this process improves IRE1α's ability to cut specific RNA sequences, which is crucial for cell survival under stress; for example, stronger dimerization of the enzyme led to a notable increase in its activity. Who this helps: This research benefits patients with secretory cancers by opening up new potential treatments.

Plain English
This study looked at a rare type of kidney cancer called mucinous tubular and spindle cell carcinoma, which has only been seen in 47 other cases before. The researchers used advanced MRI techniques to analyze the tumor's features and found that it was discovered by chance in a 35-year-old woman who was experiencing an ectopic pregnancy. Understanding this rare cancer's appearance on MRI can help doctors identify and diagnose it more effectively in the future. Who this helps: This helps doctors and medical professionals in diagnosing rare kidney cancers.

Plain English
This study looked at the training process for Army medical teams that provide surgical care during combat. Over 84 teams went through a two-week training program designed to improve their skills in handling trauma patients. Participants showed an increase in teamwork awareness, going from 71% to 95%, and nearly half of them found the hands-on clinical training to be the most valuable part. This training is crucial as it helps these teams get ready for the demanding medical conditions they'll face in war zones. Who this helps: This benefits Army medical teams and ultimately the soldiers they care for.

Plain English
This study looked at whether taking paracetamol before a specific eye treatment called panretinal photocoagulation (PRP) could help reduce pain. Sixty patients were involved, and those who took paracetamol didn't report a significant difference in pain compared to those who took a placebo; however, none of the paracetamol patients reported increased pain 24 hours later, while 21% of placebo patients did. This matters because it shows that while paracetamol might not lower pain during the procedure, it may prevent worsening pain afterward. Who this helps: This helps patients undergoing PRP treatment.

Plain English
This study looked at how reducing dietary fat affects women with early-stage breast cancer who have already undergone surgery. Out of 2,437 women, those who followed a low-fat diet (975 women) reported lower daily fat intake (33.3 grams) compared to those who didn’t change their diet (51.3 grams), resulting in an average weight loss of 6 pounds. Importantly, the women on the low-fat diet experienced fewer cancer relapses (9.8%) compared to those in the control group (12.4%), suggesting that a lower fat diet may help improve survival without cancer recurrence. Who this helps: This helps breast cancer patients seeking ways to improve their health after treatment.

Plain English
This study looked at whether creating artificial skin through tissue engineering caused genetic damage. Researchers found that tissue-engineered skin showed no increase in DNA damage or mutations related to skin cancer, specifically the common TP53 gene mutation. This is important because it confirms that current tissue-engineering processes do not negatively affect the genetic integrity of the products, supporting their safety for medical use. Who this helps: This benefits patients by ensuring that artificial skin used in treatments is safe.

Plain English
This study looks at a pregnant woman who was diagnosed with Kawasaki disease, which caused heart issues and complications during her pregnancy. She experienced heart problems at 20 weeks and had a planned cesarean section at 38 weeks due to serious health risks, including inflammation of her heart arteries and a condition where the placenta is abnormally low. Understanding these cases is important because it highlights the risks that Kawasaki disease can pose to pregnant women and their babies. Who this helps: This helps pregnant women with Kawasaki disease and their healthcare providers.

Plain English
This study focused on patients with Duchenne and Becker muscular dystrophy, particularly those with deletions in their genetic code that don't follow the expected pattern for predicting disease severity. The researchers found that while the expected pattern predicted outcomes accurately in 93% of the cases, there were notable exceptions: for example, a patient with a specific deletion produced dystrophin, a key muscle protein, while another with a different deletion did not. This matters because understanding these exceptions can help in providing more accurate predictions and treatments for patients with these conditions. Who this helps: This helps patients and doctors managing Duchenne and Becker muscular dystrophy.

Plain English
This study tested a new inactivated polio vaccine based on the well-known Sabin vaccine, focusing on how well it works in adults. Researchers found that only 69% of the 39 healthy adult males surveyed had enough immunity to all three types of poliovirus, with younger adults showing the lowest levels; notably, two men had no immunity at all. When the new vaccine was given to volunteers, everyone showed a strong immune response that lasted for at least 18 months, with no serious side effects. Who this helps: This benefits adults who may have had their immunity to polio decline over time and need protection against the virus.